The Future of Biopharma.
| Publicado en: | BioPharm International Vol. 26; no. 1; pp. 22 - 25 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Jan2013
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108043379&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 108043379 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Jan2013 vid: 26 iid: 1 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 108043379 2011969767 108043379 ppf: 22 ppct: 3 formats: fmt: @attributes: type: P tig: atl: The Future of Biopharma. aug: au: Langer, Eric S. affil: President and managing partner, BioPlan Associates, Inc sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|